Evidence map›Paper›PMID 28117528›Full record

ArticleThe breast journal2017

Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

Bradley Downs, Fengxia Xiao, Yeong C Kim, Pei Xian Chen, Dali Huang, Elizabeth A Fleissner, Kenneth Cowan, San Ming Wang

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The breast journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bradley DownsDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska.
Fengxia XiaoDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska.
Yeong C KimDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska.
Pei Xian ChenDepartment of Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Dali HuangFred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.
Elizabeth A FleissnerFred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.
Kenneth CowanFred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.
San Ming WangDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska.

Funding

(PQD3) Genetic Basis of Breast Cancer Resistance in BRCA1+ CarrierR21CA180008 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, SAN MING · 2013 to 2014
$364k
NCI NIH HHS R21 CA180008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersLoss of HeterozygosityAdultAgedBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingFemaleGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseHumansMiddle AgedBiomarkers

Identifiers

PMID28117528
PMCPMC5505784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.